CytarabineIdarubicinDaunorubicinLeukemia, Myeloid, AcuteRemission InductionConsolidation ChemotherapyAntineoplastic Combined Chemotherapy ProtocolsMitoxantroneAntimetabolites, AntineoplasticArabinonucleosidesLeukemia, MyeloidEtoposideThioguanineDrug Administration ScheduleMethotrexateInduction ChemotherapyVincristineTreatment OutcomeMeningeal CarcinomatosisPrecursor Cell Lymphoblastic Leukemia-LymphomaInjections, SpinalLeukemic InfiltrationCytidine MonophosphateAcute DiseaseCarmustineDrug AgonismAsparaginaseDisease-Free SurvivalDeoxycytidine Kinase6-MercaptopurineCyclophosphamideLymphoma, Non-HodgkinArabinonucleotidesLeukemia, Myelomonocytic, AcuteAntineoplastic AgentsDose-Response Relationship, DrugSurvival AnalysisLeukemia, Myeloid, Accelerated PhaseRecurrenceAmsacrineSurvival RateCentral Nervous System NeoplasmsVidarabineMolecular StructureSalvage TherapyArabinofuranosylcytosine TriphosphateTransplantation, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveDoxorubicinTeniposideSulfur CompoundsAnemia, Refractory, with Excess of BlastsMyelodysplastic SyndromesDexamethasoneDrug Screening Assays, AntitumorVolatile Organic CompoundsCombined Modality TherapyLeukemiaDrug Resistance, NeoplasmAdenine NucleotidesDioxolanesPodophyllotoxinMeningitisMelphalanPyrimidinesCladribineInfusions, IntravenousLeukemia, Myeloid, Chronic-PhasePiperazinesBlast CrisisPrednisoneBenzamidesStructure-Activity RelationshipAclarubicinPolyradiculopathyHarringtoninesPrognosisActuarial AnalysisDrug SynergismCytogenetic AnalysisHematopoietic Stem Cell TransplantationBurkitt LymphomaEquilibrative Nucleoside Transporter 1MeningesPlant ExtractsGranulocyte Colony-Stimulating FactorAminoglycosidesCell Line, TumorDrug Evaluation, PreclinicalCore Binding FactorsLeukemia, Promyelocytic, AcuteBone Marrow TransplantationMagnetic Resonance SpectroscopyHL-60 CellsLymphoma, Mantle-CellLeukoencephalopathy, Progressive MultifocalPhenolsHeterocyclic CompoundsInhibitory Concentration 50Biphenyl Compounds